A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer

by Bauman Julie E, Eaton Keith D, Wallace Sarah G, Carr Laurie L, Lee Sang-Joon, Jones Dennie V, Arias-Pulido Hugo, Cerilli Lisa A, Martins Renato G
Published 2012-10-01